Related Experiment Videos
Laser trabeculostimulation in open-angle glaucoma: a new trial. Part I
R Suzuki1, M Nakayama, H Yoshino
1Department of Ophthalmology, Yamaguchi University School of Medicine, Ube City, Japan.
Summary
A new laser trabeculostimulation (LTS) trial showed potential for treating glaucoma by stimulating trabecular meshwork tissue. While less effective than traditional laser trabeculoplasty, LTS offers a repeatable, add-on treatment option.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Glaucoma management often involves reducing intraocular pressure (IOP).
- Conventional laser trabeculoplasty (LTP) can cause meshwork scarring, limiting its long-term efficacy.
- Newer methods to enhance aqueous outflow are needed.
Purpose of the Study:
- To evaluate the efficacy of a novel laser trabeculostimulation (LTS) technique.
- To compare LTS with conventional laser trabeculoplasty (LTP) for IOP reduction.
- To explore LTS as a potential glaucoma treatment modality.
Main Methods:
- A trial involving 40 eyes with a mean preoperative IOP of 24.9 +/- 6.8 mm Hg.
- Application of LTS using a 50-microns spot, 50 mW power, and 1s exposure time.
- Comparison of IOP changes following LTS versus conventional LTP.
Main Results:
- Laser trabeculostimulation (LTS) initially decreased IOP, which later increased.
- Low power (50 mW) LTS demonstrated effectiveness with extended exposure duration.
- LTS was found to be repeatable and could be used adjunctively with conventional LTP.
Conclusions:
- Laser trabeculostimulation (LTS) shows promise as a novel glaucoma treatment.
- While less effective than conventional laser trabeculoplasty (LTP), LTS offers a repeatable, non-cicatrizing alternative.
- Further development of LTS may lead to a valuable new therapeutic option for managing intraocular pressure.